Literature DB >> 21684546

Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: an integrated backscatter intravascular ultrasound study.

Tetsuya Amano1, Tatsuaki Matsubara, Tadayuki Uetani, Masataka Kato, Bunichi Kato, Tomohiro Yoshida, Ken Harada, Soichiro Kumagai, Ayako Kunimura, Yusaku Shinbo, Katsuhide Kitagawa, Hideki Ishii, Toyoaki Murohara.   

Abstract

OBJECTIVE: To assess the impact of omega-3 polyunsaturated fatty acids (ω3 PUFAs) on coronary plaque instability.
METHODS: Serum content of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) was measured in 336 of 368 consecutive patients suspected of having coronary artery disease who underwent coronary angiography. Conventional and integrated backscatter intravascular ultrasound (IB-IVUS) parameters were analyzed in 116 patients with 128 coronary plaques, using a 43-MHz (motorized pullback 0.5mm/s) intravascular catheter (View It, Terumo Co., Japan). Lipid-rich plaques were classified into two categories according to their components.
RESULTS: Patients with acute coronary syndrome had significantly lower levels of ω3 PUFAs (especially of EPA and DPA) than those without it. IB-IVUS analyses showed that ω3 PUFAs correlated inversely with % lipid volume and positively with % fibrous volume. Patients with low EPA levels, low DPA levels, and low DHA levels had a significantly higher % lipid volume (p=0.048, p=0.008, and p=0.036, respectively) and a significantly lower % fibrous volume (p=0.035, p=0.008, and p=0.034, respectively) than those with high levels of these fatty acids. Even after adjustment for confounders, the presence of both low EPA and low DPA levels proved to be an independent predictor for lipid-rich plaques in any of the two categories.
CONCLUSIONS: A lower serum content of ω3 PUFAs (especially of EPA and DPA) was significantly associated with lipid-rich plaques, suggesting the contribution to the incidence of acute coronary syndrome.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684546     DOI: 10.1016/j.atherosclerosis.2011.05.030

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  22 in total

1.  Impact of tissue characteristics on luminal narrowing of mild angiographic coronary stenosis: assessment of integrated backscatter intravascular ultrasound.

Authors:  Makoto Iwama; Shinichiro Tanaka; Toshiyuki Noda; Tomonori Segawa; Masanori Kawasaki; Kazuhiko Nishigaki; Taro Minagawa; Sachiro Watanabe; Shinya Minatoguchi
Journal:  Heart Vessels       Date:  2013-10-24       Impact factor: 2.037

2.  Bioactive products formed in humans from fish oils.

Authors:  Carsten Skarke; Naji Alamuddin; John A Lawson; Xuanwen Li; Jane F Ferguson; Muredach P Reilly; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2015-07-15       Impact factor: 5.922

Review 3.  Targeting inflammation in metabolic syndrome.

Authors:  Francine K Welty; Abdulhamied Alfaddagh; Tarec K Elajami
Journal:  Transl Res       Date:  2015-07-03       Impact factor: 7.012

4.  Proximate and fatty acid composition of some commercially important fish species from the Sinop region of the Black Sea.

Authors:  Demet Kocatepe; Hülya Turan
Journal:  Lipids       Date:  2012-02-11       Impact factor: 1.880

5.  Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.

Authors:  Tarec K Elajami; Romain A Colas; Jesmond Dalli; Nan Chiang; Charles N Serhan; Francine K Welty
Journal:  FASEB J       Date:  2016-04-27       Impact factor: 5.191

6.  The Benefits of Omega-3 Fats for Stabilizing and Remodeling Atherosclerosis.

Authors:  James J DiNicolantonio; James H O'Keefe
Journal:  Mo Med       Date:  2020 Jan-Feb

7.  Aberrant serum polyunsaturated fatty acids profile is relevant with acute coronary syndrome.

Authors:  Atsushi Sakamoto; Masao Saotome; Natsuko Hosoya; Shigetaka Kageyama; Toru Yoshizaki; Ryosuke Takeuchi; Koichiro Murata; Ryuzo Nawada; Tomoya Onodera; Akinori Takizawa; Hiroshi Satoh; Hideharu Hayashi
Journal:  Heart Vessels       Date:  2015-08-02       Impact factor: 2.037

8.  Prognostic impact of lipid contents on the target lesion in patients with drug eluting stent implantation.

Authors:  Soichiro Kumagai; Hiroaki Takashima; Katsuhisa Waseda; Hirohiko Ando; Akihiro Suzuki; Tadayuki Uetani; Ken Harada; Tomohiro Yoshida; Ayako Kunimura; Yusaku Shimbo; Katsuhide Kitagawa; Kazuhiro Harada; Hideki Ishii; Daiji Yoshikawa; Tatsuaki Matsubara; Toyoaki Murohara; Tetsuya Amano
Journal:  Heart Vessels       Date:  2013-10-20       Impact factor: 2.037

9.  Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men.

Authors:  Andreas Hahn; Jan Philipp Schuchardt; Simone Schmidt; Frank Stahl; Kai-Oliver Mutz; Thomas Scheper
Journal:  Nutr Metab (Lond)       Date:  2012-05-23       Impact factor: 4.169

10.  Different gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: results from a randomized controlled trial.

Authors:  Simone Schmidt; Frank Stahl; Kai-Oliver Mutz; Thomas Scheper; Andreas Hahn; Jan P Schuchardt
Journal:  Lipids Health Dis       Date:  2012-08-29       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.